>Pennsylvania State University to establish an acceptable nutrient credit calculation and verification methodology for the Kreider Farm project, which was approved by the DEP in mid-2008. The DEP approval projects a credit total in the range of 140 nutrient credits per milk cow's waste treated; and perhaps most significantly, a majority of these credits will be generated from airborne ammonia reductions. Ammonia air emissions from CAFOs are for the most part quickly re-deposited onto neighboring lands, which simply advances the nitrogen molecule's travels towards the Chesapeake Bay. A listing of Bion's credits is posted on the PA DEPs trading website at http://www.dep.state.pa.us/river/Nutrient%20Trading_files/ProposalRegistryandTradableLoadTracking.xls
. Bion's treatment system will not only reduce nutrient impacts on the Chesapeake Bay, it will also significantly reduce local environmental impacts such as odor, phosphorus releases to the local creeks, a host of air emissions such as hydrogen sulfide and methane (greenhouse gas emissions), as well as pathogens.
More than 40 states have announced plans to develop nutrient trading programs, with Pennsylvania's program being the most advanced. Nutrient trading programs encourage nitrogen and phosphorous reductions from non-point source facilities (such as agriculture and livestock facilities) by providing a program to sell credits for those reductions. These certified nutrient credits can be used by point source facilities such as municipal wastewater treatment plants, with much higher remediation costs, to offset their own nutrient discharges. The premise is that the same nutrient reduction to the environment can be achieved at a significantly reduced cost to the community.
Bion has worked closely with both the federal and state regulatory agencies
Page: 1 2 3 4 Related biology technology :1
|SOURCE Bion Environmental Technologies, Inc.|
Copyright©2009 PR Newswire.
All rights reserved
. Medarex Announces Allowance of Investigational New Drug Application for Companys First Antibody-Drug Conjugate, MDX-12032
. XTL Biopharmaceuticals Announces Receipt of NASDAQ Notice of Delisting3
. Calvert Labs Announces the Hiring of Terry Ladd 4
. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2008 Financial Results5
. Indevus Pharmaceuticals Announces Release of 2008 Annual Report6
. Fadel Partners Announces 13% Growth Despite IT Services Industry Downtrend7
. Cardium Announces Retirement of Director8
. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2008 Earnings Conference Call9
. Novavax Announces Operational Status of Its Vaccine Pilot Plant and Commercial Launch Facility10
. AMDL, Inc. Announces 2009 Financial Guidance and First Quarter Business Objectives11
. Netsmart University Announces Partner Referral Agreement With New York Association of Alcohol and Substance Abuse Providers